Volume 2 (2018) – 45 articles
Cover Picture: Colorectal cancer (CRC) is a common health problem due to its high prevalence and high mortality rate. Adjuvant and neo-adjuvant strategies, chemotherapy and radiotherapy alone or in combination, have substantially improved survival and local recurrence rates. Their effectiveness remains limited due to the intrinsic build-up of resistance of cancer cells to chemotherapy drugs, dose-limiting toxicities and other major side effects. New strategies to overcome these issues are being developed, one of which is cancer nanomedicine, a rapidly developing interdisciplinary research field. The last few decades have seen a rapid growth of interest in utilising nanoparticles and nanotechnology in cancer medicine. This is mainly due to the suitable physical and chemical properties of nanoparticles for in vivo applications. Cancer nanomedicine for targeted drug delivery and imaging has been widely investigated preclinically and clinically. Nanomedicine has been considered as a novel solution to enhance CRC diagnosis and treatment, both separately and in combination using theranostic techniques. This review highlights the research, opportunities, and challenges for the development of nanoplatforms for diagnosing and treating CRC.
view this paper
Read Online Viewed:
Download This Volume Viewed:
